CRNX.D

Crinetics Pharmaceuticals, Inc.

Healthcare · Biotechnology

$281.68 sample

+2.63 (+0.94%) 1D

Market cap

$755.8B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-28

Alerts

8

Price$281.68 -0.23% 3M daily closessample

295.22265.83

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19INSInsider buy: Chief Financial Officer
Oct 13INSInsider buy: Chief Financial Officer
Oct 06INSInsider sell: 10% owner
Oct 01INSInsider sell: General Counsel
Sep 28SEC10-Q filed
Sep 21INSInsider buy: EVP, Operations
Sep 14INSInsider buy: Director
Sep 03INSInsider sell: General Counsel

Sign up to see the real CRNX.D record →

Company facts

SEC EDGAR registration

Name: Crinetics Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -4sample, -100 to +100
Reporting currency: USD

Who is positioning in CRNX.D

sample

Insiders: 13 insider transactions over 90 days, net selling, $148.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 27 funds hold $6.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.9B +12.5% y/y

Q4 2024Q3 2026

Inventory$15.3B +17.8% y/y

Q4 2024Q3 2026

Accounts receivable$11.0B +5.1% y/y

Q4 2024Q3 2026

Total debt$30.1B +6.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $574.2B -0.8% 3M
Sample peer B: $677.1B +13.7% 3M
Sample peer C: $85.2B -1.2% 3M
Sample peer D: $259.1B -11.7% 3M
Sample peer E: $496.6B +9.8% 3M